How are Government Initiatives Driving Aortic Valve Market?

1. Biological Aortic Valves Conducive for Elderly 1 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

2. Factors such as increasing prevalence of valvular diseases and rising number of initiatives for imparting awareness regarding valve replacement are expected to supplement the aortic valve market growth at a CAGR of 13.2% during the forecast period (2020–2030). At this rate, the market’s value will increase from $7,568.3 billion in 2019 to $29,146.9 million by 2030. Currently, the market is witnessing the trend of product launches. Manufacturing companies are continuously focusing on developing new and improved products to meet the spurring demand for aortic valves, across the world. Receive Sample Pages of this Report: https://www.psmarketresearch.com/market-analysis/aortic-valve- market/report-sample Aortic regurgitation and aortic stenosis are the most common valvular diseases. Rheumatic heart disease (RHD) is the most common cause of aortic regurgitation. According to the World Health Organization (WHO), nearly 33 million people around the globe are affected by RHD that accounts for around 2% of the population suffering from cardiovascular diseases (CVDs). These conditions mostly affect the old people. Thus, booming geriatric population will fuel the consumption of aortic valves in the coming years, which, in turn, will drive the market growth. Another key factor driving the aortic valve market is the growing support from governments, worldwide. Government organizations are taking multiple initiatives to impart knowledge regarding aortic valve replacement procedures. For instance, the European Association of Percutaneous Cardiovascular Interventions (EAPCI) launched Valve for Life initiative in Europe, in 2015. It aims to improve the access to transcatheter valve procedures, enhance the educational standards for healthcare professionals, raise awareness regarding valvular diseases, decrease obstacles for therapy implementation, and end age and gender discrimination in access to medical care, in the region. Aortic valves are available as mechanical and tissue/biological valves. With constant developments in technology and rapid demand for valves from the ageing population, medical professionals are primarily opting for biological or tissue aortic valves. These valves are implanted in the human body either through open surgery or minimally invasive surgery (MIS). The surgeons are preferring MIS implantation procedure, as it causes lesser trauma to the patients and stimulates the recovery process, in comparison to open-heart surgeries. These products and procedures are used in several healthcare facilities. Thus, the end-user segment of the aortic valve market is bifurcated into hospitals and ambulatory surgery centers (ASCs). Between the two, the hospitals category will exhibit the fastest growth in the forecast period. This growth can be attributed to 2 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

3. the fact that hospitals are the most advanced facilities and offer optimal patient care. Moreover, surging healthcare spending and an improving healthcare reimbursement structure will propel the growth of the market in this category in the coming years. According to P&S Intelligence, Europe generated the maximum demand for aortic valves in 2019 and it will retain its dominance in future, due to the existence of an advanced healthcare system, growing elderly population, and increasing incidence of chronic and lifestyle-associated diseases. Furthermore, the European market is expected to witness the fastest growth during the forecast period. This can be due to the rising cases of aortic stenosis in western European nations. Doctors generally recommend transcatheter aortic valve replacement (TAVR) and surgical valve replacement treatments for aortic stenosis. Thus, intensifying awareness among people and healthcare professionals regarding aortic valves and replacement procedures will fuel the adoption of these valves in the future. The research offers market size of the breast biopsy devices for the period 2013–2023. Market Segmentation by Product Guidance Systems Biopsy Needles/Guns Biopsy Tables Biopsy Wires Others Market Segmentation by Procedure Type Vacuum-Assisted Biopsy Core Needle Biopsy Fine Needle Aspiration Biopsy Surgical Biopsy Market Segmentation by Imaging Modality Mammography Guided Stereotactic Biopsy Ultrasound Guided Biopsy Magnetic Resonance Imaging (MRI) Guided Biopsy Computed Tomography (CT) Guided Biopsy Others Market Segmentation by Geography North America Breast Biopsy Devices Market • • • • • • • • • • • • • • • oBy Product 3 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

4. oBy Procedure Type oBy Imaging Modality oBy Country – U.S. and Canada Europe Breast Biopsy Devices Market • oBy Product oBy Procedure Type oBy Imaging Modality oBy Country – Germany, France, U.K., Italy, Spain, and Rest of Europe Asia-Pacific (APAC) Breast Biopsy Devices Market • oBy Product oBy Procedure Type oBy Imaging Modality oBy Country – Japan, China, India, Australia and Rest of APAC Rest of the World (RoW) Breast Biopsy Devices Market • oBy Product oBy Procedure Type oBy Imaging Modality oBy Country – Brazil, Mexico and Rest of RoW 4 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

5. Disclaimer: P&S Intelligence always keeps its customers’ interests at the core while carrying out research activities. P&S Intelligence ensures the reliability and accuracy of information and data provided in its market research publications. However, the information in publications is subject to fluctuations, as it is based on primary interviews of officials from various companies or organizations. P&S Intelligence is not responsible for any incorrect data provided by the key industry players of the concerned domain. The information or analysis in P&S Intelligence publications represents opinions based on research and should not be interpreted as statements of fact. Information in this report was believed to be correct at the time of publication, but cannot be guaranteed. P&S Intelligence does not endorse any product, service, or vendor depicted in its research publications. All intellectual properties, including trademarks and copyrights, belong to their respective owners and may be protected by copyright. Under no circumstance can these be reproduced in any form without prior written agreement of their owners. An order for market research report is intended for internal use of the company only and not for disclosure to third parties or any other publication in general. No service, report, or part thereof provided by P&S Intelligence can be reproduced, republished, resold, revealed, distributed, circulated, or sublicensed in any medium or form now realized or hereafter become realized, including but not limited to, all forms of optical-based media, magnetic, electronic, or digital, without a written permission from Prescient & Strategic Intelligence Pvt. Ltd. Kindly write to: enquiry@psmarketresearch.com B-13, Sector – 2, Noida, U.P. – 201301, INDIA Contact No: +91 120 4541 337 US/Canada Toll-Free: 1-888-778-7886 5 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved